Autophagy-related protein expression in the substantia nigra and eldepryl intervention in rat models of Parkinson's disease

Brain Research
Bin LiuChaonan Lv

Abstract

Autophagy has been shown to participate in the pathogenesis of Parkinson's disease (PD), but its precise mechanism remains poorly understood. This study observed autophagy, autophagy-related protein Beclin1 and microtubule-associated protein 1 light chain 3 (LC3) expression in substantia nigra, and eldepryl effects on their expression, as well as explored autophagy effects on the onset of PD and the mechanism of action of eldepryl on PD in rat models. Models of PD were established by subcutaneous injection of rotenone through back of the neck. Results indicated that Beclin1, LC3 protein expression and LC3II/LC3I ratio were higher in substantia nigra of rats in the model group compared with the control group. Beclin1, LC3 protein expression and LC3II/LC3I ratio were higher at 8 days than that at 4 days in the model group, showing significant differences. Beclin1, LC3 protein expression and LC3II/LC3I ratio were lower in the rat substantia nigra of the eldepryl group than in the model group. Beclin1, LC3 protein expression and LC3II/LC3I ratio were lower at 8 days than at 4 days in the eldepryl group, showing significant differences. Results suggested that autophagy plays a key role in the onset of PD. Eldepryl exerts therapeutic...Continue Reading

References

Feb 1, 2003·Journal of Neurochemistry·Günter U HöglingerEtienne C Hirsch
Apr 11, 2003·Neuroscience Letters·Todd B ShererJ Timothy Greenamyre
Jul 10, 2003·Trends in Neurosciences·Céline PerierSerge Przedborski
Aug 14, 2003·Parkinsonism & Related Disorders·J Timothy GreenamyreTodd B Sherer
Aug 25, 2004·The International Journal of Biochemistry & Cell Biology·Noboru Mizushima
Aug 25, 2004·The International Journal of Biochemistry & Cell Biology·Isei TanidaEiki Kominami
Oct 13, 2004·Neurology·Peter A LeWitt
Jan 13, 2006·British Journal of Pharmacology·Moussa B H Youdim, Y S Bakhle
Feb 21, 2006·Antioxidants & Redox Signaling·Roberta KiffinAna Maria Cuervo
Nov 3, 2006·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Jian Feng
Jul 24, 2007·Autophagy·Shlomit ErlichRonit Pinkas-Kramarski
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·John J ShackaJianhua Zhang
Jan 12, 2008·Brain : a Journal of Neurology·Tianhong PanJoseph Jankovic
Jan 15, 2008·Cell·Beth Levine, Guido Kroemer
May 23, 2009·Journal of Cell Science·Brinda RavikumarDavid C Rubinsztein
Apr 3, 2010·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Qian Yang, Zixu Mao
Apr 16, 2010·Canadian Journal of Physiology and Pharmacology·Yongqiang ChenSpencer B Gibson
Jun 24, 2010·Current Opinion in Gastroenterology·Alan HuettRamnik J Xavier
Aug 12, 2010·Current Pharmaceutical Design·Makoto Naoi, Wakako Maruyama
Aug 18, 2010·The Journal of Cell Biology·Salvatore J CherraCharleen T Chu
Jan 18, 2011·Developmental Cell·Tomer Shpilka, Zvulun Elazar
Jan 22, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Frank Tacke, Christian Trautwein
Jan 29, 2011·Current Drug Targets·R X SantosP I Moreira
Mar 23, 2011·Expert Reviews in Molecular Medicine·Maria Xilouri, Leonidas Stefanis
Apr 13, 2011·Medical Hypotheses·B LoosA-M Engelbrecht
Mar 13, 2012·International Journal of Environmental Research and Public Health·Syed F AliSyed Z Imam
Apr 5, 2012·Cold Spring Harbor Perspectives in Medicine·Melinda A Lynch-DayDaniel J Klionsky
Apr 18, 2012·Brain : a Journal of Neurology·Tamara ShinerRaymond J Dolan
May 18, 2012·Clinical Neuropharmacology·Giovanni FabbriniMario Zappia
Jul 18, 2012·Bulletin of Experimental Biology and Medicine·A A UstyugovN N Ninkina
Apr 13, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Benjamin DehayErwan Bezard
Jul 17, 2013·Nature Reviews. Neurology·Joanne Trinh, Matt Farrer
Aug 6, 2013·Acta Neuropathologica·Christiane Richter-Landsberg, Janina Leyk
Aug 8, 2013·Nature Medicine·Ralph A Nixon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.